Cargando…
Non-specific effects of standard measles vaccine at 4.5 and 9 months of age on childhood mortality: randomised controlled trial
Objective To examine in a randomised trial whether a 25% difference in mortality exists between 4.5 months and 3 years of age for children given two standard doses of Edmonston-Zagreb measles vaccines at 4.5 and 9 months of age compared with those given one dose of measles vaccine at 9 months of age...
Autores principales: | Aaby, Peter, Martins, Cesário L, Garly, May-Lill, Balé, Carlito, Andersen, Andreas, Rodrigues, Amabelia, Ravn, Henrik, Lisse, Ida M, Benn, Christine S, Whittle, Hilton C |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group Ltd.
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2994348/ https://www.ncbi.nlm.nih.gov/pubmed/21118875 http://dx.doi.org/10.1136/bmj.c6495 |
Ejemplares similares
-
Protective efficacy of standard Edmonston-Zagreb measles vaccination in infants aged 4.5 months: interim analysis of a randomised clinical trial
por: Martins, Cesário L, et al.
Publicado: (2008) -
A Randomized Trial of a Standard Dose of Edmonston-Zagreb Measles Vaccine Given at 4.5 Months of Age: Effect on Total Hospital Admissions
por: Martins, Cesario L., et al.
Publicado: (2014) -
Measles Vaccination in the Presence or Absence of Maternal Measles Antibody: Impact on Child Survival
por: Aaby, Peter, et al.
Publicado: (2014) -
The optimal age of measles immunisation in low-income countries: a secondary analysis of the assumptions underlying the current policy
por: Aaby, Peter, et al.
Publicado: (2012) -
Interaction between neonatal vitamin A supplementation and timing of measles vaccination: A retrospective analysis of three randomized trials from Guinea-Bissau()
por: Benn, Christine S., et al.
Publicado: (2014)